Alzheimer Disease.

Abstract

Alzheimer disease is due to increased amyloid-β coupled with low progranulin. Several brain imaging techniques are helpful in the diagnosis. Drugs available for treating Alzheimer disease have limited clinical utility. Cognitive stimulation therapy is an effective therapy for persons with moderate Alzheimer disease.

• Authors: John E Morley, Susan A Farr, Andrew D Nguyen
• Journal: Clinics in geriatric medicine (Clin Geriatr Med) Vol. 34 Issue 4 Pg. 591-601 (11 2018) ISSN: 1879-8853 [Electronic] United States
• PMID: 30336989 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2018 Elsevier Inc. All rights reserved.

Chemical References

• Amyloid beta-Peptides
• Progranulins

Topics

• Aged
• Alzheimer Disease (diagnosis, genetics, metabolism, therapy)
• Amyloid beta-Peptides (genetics, metabolism)
• Brain (diagnostic imaging)
• Cognitive Behavioral Therapy (methods)
• Disease Management
• Genetic Predisposition to Disease
• Humans
• Neuropsychological Tests
• Progranulins (genetics, metabolism)